2/21/2013

Cytomedix has announced a "comprehensive 2013 financing plan" that it hopes will allow the company to raise as much as $27.5 million. The Maryland-based firm, which specializes in regenerative therapies, said the funding plan will allow it to "confidently execute" its business strategies for this year.

Related Summaries